Settings Today

Regeneron requests emergency use approval for antibody treatment taken by Trump; stock rises 4% in premarket

Regeneron's stock price rose over 4% in premarket trade Thursday.

Published 1298 days ago

Go Back to Reading NewsBack Read News Collect this News Article

© 2024 - ErnesTech - Privacy
E-Commerce Return Policy